Nutritional Growth Solutions Ltd (NGS) TRADING HALT SUSPENDED

20mins delayed

Movement

1 Year Return


Nutritional Growth Solutions Ltd Chart

Share price
Last
Change
Volume
Turnover
Market Cap $13.77 million
Today's Movement
Prev. Close
Open
Day Range -
VWAP
Historical Stats
52w Range -
4w Avg Volume
4w Avg Turnover
(delayed)

NGS Statistics

26 November

1,830 / 2,244

ASX Size Rank

1yr Return

vs Sector (1yr)

+3.35%

vs ASX 200 (1yr)

+8.05%

$13.77 million

Market Cap

Share Issue

43.03 million

All Ords (%)

N/A

Short Sold

0%

Current Fundamentals

26 November

N/A

PE Ratio

EPS ($)

-

Earnings Yield

-

NTA ($)

-

0.00%

Dividend Yield

DPS ($)

-

Gross Div. Yield

-

Gross DPS ($)

-

Company Overview

Nutritional Growth Solutions Ltd (NGS) is a global nutritional health company focused on the well-being of children. NGS develops, produces and sells clinically tested nutritional supplement formulae for children following 20 years of medical research into paediatric nutrition at Schneider Children's Medical Centre, Israel's paediatric hospital.

Nutritional Growth Solutions Ltd Logo

Corporate Details

Head Office: Tel Aviv
Managing Director: Liron Fendell
GICS Sub-Industry: Personal Products
Date Listed: 30 Oct 2020
Registry: -
Similar Companies: BKL / BWX / AHY / MCP / EHH

Upcoming Calendar

Dividend History

Ex-Date Amount Franking Type Payable
No dividends paid in the last 5 years

See Upcoming Dividends for all ASX companies.

Announcements

Date Heading Pages File Size Time

Announcements provided by

Broker Consensus

The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.

NGS is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.

Directors & Management

About the Data


Name Title Since Bio
Ms Liron Fendell Chief Executive Officer, Managing Director Oct 2020
Dr Kinneret Livnat Savitzky Non-Executive Director Oct 2020
Mr Brian Willoughby Leedman Non-Executive Chairman, Non-Executive Director Sep 2020
Dr Anton Uvarov Non-Executive Director Oct 2020
Professor Raanan Shamir Chief Medical Officer, Executive Director Jan 2014
Mr Amir Zaidman Non-Executive Director Oct 2020

Director Transactions

About the Data

NGS directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

There are no director transactions for code NGS in our database.

Shareholder Distribution

Shareholder Distribution data is unavailable.

Top 20 Shareholders

About the Data

Name Shares Capital
MOR Research Applications Ltd 12,604,790 13.31%
Ms Hadassa Bymel 8,098,652 8.55%
Prof Phillip Moshe 5,028,720 5.31%
Moshe Cohen 4,532,143 4.79%
Prof Raanan Shamir 4,465,470 4.71%
Prof Lazar Liora 3,151,184 3.33%
Dr Michal Gavan 3,151,184 3.33%
ARQ Capital Pty Ltd(Nitsche Family A/C) 1,759,821 1.86%
Impact Equities Pty Ltd 1,693,750 1.79%
Ms Yulia Uvarova (Techinvest Nominees A/C) 1,689,290 1.78%
Brian And Natasha Leedman 1,500,000 1.58%
Mr Loh Kok Wah 982,143 1.04%
Papillon Holdings Pty Ltd (The Vml No 1 A/C) 946,875 1.00%
Edwin Edward & Allison Bulseco (Kc Bulseco Family A/C) 821,875 0.87%
Retzos Executive Pty Ltd (Retzos Executive S/Fund A/C) 816,913 0.86%
Lachlan 11 Holdings Pty Ltd (Reid Family A/C) 800,000 0.84%
Kava Investments Pty Ltd (Rapid Trading A/C) 750,000 0.79%
Ms Kathryn Macdonald & Mr Christopher Stewart Macdonald (Macdonald Super Fund A/C) 750,000 0.79%
Flinders Medical Centre Foundation 674,995 0.71%
Altor Capital Managementpty Ltd(Altor Alpha Fund A/C) 657,143 0.69%
Mrs Elena Tsvetnenko (Yuri And Elena A/C) 640,000 0.68%
Mr Narinder Singh Sudagar Singh (Sidhu A/C) 608,929 0.64%
All other shareholders 40.75 %


The Top 20 Shareholders of NGS hold 59.25% of shares on issue.

NGS Share Price History

Date Close Change % Change Open High Low Volume Turnover

NGS Historical Data

Download up to 20 years of share price history.


Year Closing Price (30 June) Last Trade

Offical data as published by ASX. See more Data Downloads.

Company Details

Principal Activity: NGS develops, produces and sells clinically tested nutritional supplement formulae or children.

Incorporated: --

4 Berkovich St
Tel Aviv Israel 6423806


All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.